Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 183A pseudogene 1 (TMEM183AP1) is classified as a pseudogene in humans. Unlike its parent gene TMEM183A, which encodes a mitochondrial membrane protein with an unknown function, TMEM183AP1 itself does not produce a functional protein product and is not known to have a biological role or disease association. As a pseudogene, it does not classify as a receptor, enzyme, transporter, or therapeutic target. There is no evidence of drug interactions, disease association, or biomarker utility for TMEM183AP1, and it is not associated with any known therapeutic or safety concerns. TMEM183A, the parent gene, encodes a mitochondrial membrane protein and is under investigation for potential regulatory roles, but this does not apply to TMEM183AP1, which is a non-coding pseudogene. Some sources catalog TMEM183AP1 under related gene clusters, but always note its pseudogene status, indicating no protein or known function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 183A pseudogene 1 (TMEM183AP1).